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Introduction
Acyl glucuronidation is one of the major metabolic routes of drugs that contain carboxylic acid moieties. Glucuronidation is one of the most important phase II metabolic pathways for endogenous and exogenous substrates and is generally considered a detoxification pathway. However, it is well known that acyl glucuronides (AGs) are unstable under physiological conditions and consequently undergo hydrolysis or intramolecular rearrangement through the migration of the drug moiety from the 1-O-position to the 2-, 3-, and 4-positions on the glucuronic acid ring (Smith et al., 1990; Benet et al., 1993; Bailey and Mickinson, 2003) . AGs covalently modify endogenous proteins due to their electrophilic capacity to cause substitution reactions with the nucleophilic groups located on proteins or other macromolecules, and this effect can ultimately lead to adverse drug toxicities associated with carboxylic acid-containing drugs (Fead, 1984; Boelsterli, 2002) . To date, both direct toxic effects and immune-mediated toxicity have been suggested as possible mechanisms of idiosyncratic liver injury. With direct toxicity, covalent protein binding via AG may disrupt the normal physiological function of a "critical" protein or some critical regulatory pathway to lead to cellular necrosis (Pirmohamed et al., 1996) . In addition, it has been reported that electrophilic AGs can covalently interact with nucleic acids. Clofibrate AG and gemfibrozil AG can form DNA adducts that result in genotoxicity, and these adducts can be measured through a single-cell gel electrophoresis (comet) assay (Sallustio et al., 2006) . Furthermore, probenecid and clofibric acid have been found to induce DNA damage in isolated hepatocytes and UDP-glucuronosyltransferase (UGT)-transfected HEK293 (HEK/UGT) cells via a glucuronidation-dependent pathway (Sallustio et al., 2006; Southwood et al., 2007) . Thus, there is increasing evidence that the formation of drug-protein adducts is involved in idiosyncratic reactions. However, we previously This article has not been copyedited and formatted. The final version may differ from this version. reported that the AGs of naproxen, diclofenac, ketoprofen, and ibuprofen do not lead to cytotoxicity or genotoxicity in HEK/UGT cells and human hepatocytes (Koga et al., 2011) . Therefore, it is necessary to elucidate the possibility of immune-and/or inflammation-mediated toxicity to clarify the toxicity of AG. The potentially fatal adverse drug reactions most often appear to be immunologically based. These include anaphylactic reactions and severe dermatological reactions, such as Stevens-Johnson syndrome and fatal epidermal necrolysis (Bailey et al., 2003) . In fact, it has been reported that mycophenolic acid, which is the active metabolite of the immunosuppressant mycophenolate mofetil, is primarily metabolized by glucuronidation to form an AG, which was found to result in the induction of cytokine (TNFα and IL-6) formation in leukocytes in a cell-based study (Wieland et al., 2000) . It could be envisaged that the induction of immune modulators can lead to immune-and/or inflammation-related adverse drug reactions.
Of the drugs containing carboxylic acid moieties, diclofenac (Dic), probenecid (Pro), tolmetin (Tol), ibuprofen (Ibu), and naproxen (Nap), and their AGs were selected for the present study (Fig. 1) . These drugs containing carboxylic acid are associated with some degree of hepatotoxicity, immune cytopenias, and hypersensitivity reactions in patients (Bailey and Dickinson, 2003) and have been categorized as potentially IDT drugs in RxList (the internet drug index system) or in Japanese drug labeling. Therefore, it is suggested that the AGs of these drugs may be related to their toxicity. The purpose of this study was to investigate whether AGs induce the observed cytotoxicity, particularly through inflammatory responses, and to clarify the involvement of cell signaling in the cytotoxicity.
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Materials and Methods
Materials
Diclofenac sodium salt (Dic) and (S)-(+)-6-methoxy-α-methyl-2-naphthaleneaceatic acid (Nap) were purchased from Sigma-Aldrich (St. Louis, MO). Ibuprofen (Ibu) and probenecid (Pro) were purchased from Wako Pure Chemicals (Osaka, Japan). Tolmetin Li-COR Biosciences (Lincoln, NE). All of the primers were commercially synthesized at Hokkaido System Sciences (Sapporo, Japan). All other reagents were of the highest commercially available grade.
Cell culture
The human monocytic leukemia cell line THP-1 was obtained from Riken Gene Bank (Tsukuba, Japan 
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
The total RNA was extracted from each cell using RNAiso (Takara Bio, Shiga, Japan) according to the protocol supplied by manufacturer. The reverse transcription was performed with ReverTra Ace (Toyobo, Tokyo, Japan) according to the manufacturer's protocol. For quantitative analysis of the mRNA levels of inflammatory cytokines, real-time RT-PCR was performed using an MX3000P real-time PCR system (Stratagene, La Jolla, CA). The primers used in this study were human IL-8 (forward:
5'-CAGCCTTCCTG ATTTCTCTGCAG-3', reverse:
5'-AGACAGAGCTCTCTTCCATCAG-3') and human MCP-1 (forward 5'-ACCGAGAGGCTGAGACTAAC-3', reverse:
5'-CAGGTGACTGGGGCATTGAT-3'). A 1-μl volume of the reverse-transcribed 5'-TGGGTGGCAGTGATGGCATGGA-3').
Enzyme-linked immunosorbent assay (ELISA)
The levels of the inflammatory chemokines IL-8 and MCP-1 in the cell supernatants were measured using the Human IL-8 ELISA Ready-SET-GO! TM and Human CCL2
(MCP-1) ELISA Ready-SET-GO! TM kits (eBioscience, San Diego, CA), respectively, according to the manufacturer's instructions.
Immunoblot analysis
SDS-polyacrylamide gel electrophoresis and immunoblot analysis were performed.
The cell homogenates (30 μ g) were separated on 10% polyacrylamide gels and 
Flow cytometry analysis
The PBMCs were washed with PBS containing 0.1% BSA. The cells were transferred to a 96-well plate and maintained on ice throughout the procedure until their analysis by flow cytometry. The PBMCs were stained using the following monoclonal
The monoclonal antibodies were diluted 1:10 in PBS/0.1% BSA, and the PBMC were incubated with these antibodies for 30 min in the dark. The PBMCs were washed and subsequently incubated with PI (0.625 µg/mL) or 7-AAD (0.25 µg/mL), and the cell viability was measured using an Attune Acoustic Focusing Cytometer (Applied Biosystems, Foster, CA).
Statistical analyses
The data are presented as the means ± SD. The comparison of the multiple groups was performed using ANOVA followed by Dunnett's or Turkey's test. Differences with a p value of less than 0.05 were considered statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. 3B). The time-dependent changes in the IL-8 and MCP-1 mRNA levels were reflected at the protein level (Fig. 3C) ; thus, the subsequent experiments mainly analyzed the changes in mRNA expression.
Effects of Dic-AG on cell populations of human PBMCs
The effect of Dic-AG on the major cell populations of PBMCs (monocytes, T-lymphocytes, and B-lymphocytes) was investigated by flow cytometric analysis. The
PBMCs were stained with fluorescent monoclonal antibodies against CD3
(T-lymphocyte), CD14 (monocyte), and CD19 (B-lymphocyte) and labeled with 7AAD
or PI to detect the dead cells. Treatment with Dic-AG markedly decreased the subset of CD14 + cells of the total cells in a dose-and time-dependent manner (Fig. 4) . This effect was not observed with Dic treatment. In addition, Dic-AG showed no inhibitory effect on either the CD3 + cell population or the CD19 + cell population (Fig. 4) . These results suggest that Dic-AG specifically affects the viability of CD14 + cells. were significantly suppressed by pretreatment with their specific inhibitors (Fig. 5) .
Effects of various
Effects of MAPK inhibitors on Dic-AG-induced inflammatory factors and viability of CD14 + cells in human PBMCs
To clarify which MAP kinase signaling pathway is mainly involved in the increase 
Discussion
There is increasing evidence that the formation of drug-protein adducts is involved in idiosyncratic drug toxicities (IDT). However, little direct evidence demonstrates a link between drug-protein adduct formation and adverse biological consequences. It is well known that AGs are characterized by their electrophilic reactivity, and this reactivity is implicated in a wide range of adverse drug effects, including drug hypersensitivity reactions and cellular toxicity (Ritter, 2000) . We previously revealed that the AGs of various NSAIDs, such as naproxen, diclofenac, ketoprofen, and ibuprofen, showed no direct cytotoxicity and genotoxicity in human hepatocytes and cells stably expressing human UGTs (Koga et al., 2011) . Therefore, in this study, we investigated whether the AGs exert toxicity through inflammation-related responses. Our previous research revealed that some drugs, such as albendazole, terbinafine, and amiodarone, stimulate THP-1 cells to release IL-8, which suggests the involvement of an inflammation-mediated pathway in drug-induced adverse reactions (Mizuno et al., 2010 and Endo et al., 2012) . Furthermore, it has been reported that cytokines and chemokines, such as MCP-1, are released by THP-1 cells and PBMCs after treatment with flavonoids or amyloid proteins (Song et al., 2009) . Thus, the expression levels of IL-8 and MCP-1 as markers for predicting the activation of the inflammatory response induced by AGs were investigated in the present study.
First, the effects of Dic-AG treatment on three different types of cells, namely THP-1 cells, PBMCs, and total liver cells, were compared. We previously revealed that the NSAIDs AGs that were produced in the cells are efficiently released from the cells into the culture medium (Koga et al., 2011) . Thus, effect of AGs was evaluated by exposing the AGs to the outside of the cells, i.e., the culture medium. In a preliminary study, we found that Dic-AG treatment increases IL-8 production in human PBMCs (data This article has not been copyedited and formatted. The final version may differ from this version. not shown). Therefore, three cell types, namely THP-1 cells, PBMCs, and total liver cells, were exposed to Dic-AG treatment, and the treatment effects were compared. The expression levels of IL-8 and MCP-1 were significantly increased in THP-1 cells and PBMCs but not in total liver cells (Fig. 2) . It has been reported that some inflammatory factors, such as IL-8, IL-10, and MCP-1, are released from mixed cell culture at a much higher level than that obtained from pure monocytes treated with proteins or chemicals (Feng et al., 2008) . In addition, it has been reported that primary PBMCs are more sensitive to drugs and/or chemicals than tumor cells (Hougee et al., 2005) . In this study, Of the commercially available NSAIDs AGs, Dic-AG, Pro-AG, and Tol-AG induced the expression of IL-8 and MCP-1 and decreased the viability of CD14 + cells.
However, Ibu-AG and Nap-AG had no effect (Figs. 4 and 5) . It was reported that the half-lives of Dic-AG, Pro-AG, and Tol-AG in potassium phosphate solution or human serum albumin are shorter than those of Ibu-AG and Nap-AG (Sawamura et al., 2010) .
Furthermore, a covalent binding study using a small peptide demonstrated that the degree of AG reactivity is affected by its chemical structure (Wang et al, 2004) was hypothesized that the benzoic acid derivative exhibits the lowest reactivity due to the resonance stabilization provided by the aromatic moiety and that the isopropionic acid derivative displays a lower reactivity than that of the acetic acid derivative likely due to the higher steric hindrance capacity of the isopropyl group compared with the acetyl group (Wang et al., 2004) . These reports suggest that the stability of AGs serve as a useful key predictor for their IDT risk. Thus, it was surmised that the observed increase in the levels of inflammatory factors and the cytotoxicity of CD14 + cells by Dic-AG, Pro-AG, and Tol-AG may be related to the structural properties of the AGs.
Dic-AG is one of the most studied AGs due to its related toxicity. Dic-AG is excreted into bile and transported to the small intestine, where it can produce erosions and ulcers in a dose-dependent manner in rats (Seitz and Boelsterli, 1998) . Dic is metabolized to Dic-AG by UGT2B7 and to 4'-hydroxy Dic (4'-OH Dic) and 5-hydroxy Dic (5-OH Dic) by CYP2C9 and CYP3A4, respectively. These hydroxides are further metabolized to form benzoquinone imine, which leads to the production of oxidative stress and covalent binding with endogenous proteins (Tang et al., 1999) . Of these metabolites, 4'-OH Dic and Dic-AG increased the expression levels of IL-8 and MCP-1 (Fig. 6 ). The inducibility of these genes by Dic-AG was much higher than that obtained with 4'-OH Dic, which
suggests that Dic-AG shows the highest cytotoxicity among these metabolites. It appeared important to evaluate the toxicity of not only the AG but also the quinone imines of Dic.
The activation of MAP kinases, such as ERK1/2, p38 MAP kinase, and JNK1/2, is important for the mediation of the monocyte and macrophage functions, including the activation of various transcription factors, the production of pro-inflammatory cytokines, and cell death (Payne et al., 1991; Defranco et al., 1998) . In this study, Dic-AG activated the p38 MAP kinase and JNK1/2 pathways in PBMCs (Fig. 7A) . The blocking of these This article has not been copyedited and formatted. The final version may differ from this version. (Guha and Mackman, 2001; Isalam et al., 2006) . To determine the involvement of MAP kinases in the Dic-AG-induced increase in the expression levels of IL-8 and MCP-1 and the cytotoxicity to CD14 + cells, blocking studies were performed using specific inhibitors of these MAP kinases, including U0126, SB203580, and SP600125 (English and Cobb, 2002) . In this study, the p38 MAP kinase pathway was shown to be involved in the stimulation of the increase in the expression levels of IL-8 and MCP-1 in PBMCs (Fig.   8A ) and the cytotoxicity to CD14 + cells (Fig. 8B ). In the future, it should be clarified whether CD14 + monocytes are the main source of cell death-related inflammatory cytokines and chemokines (IL-8 and MCP-1) after the treatment of PBMCs with a drug.
Notably, the circulating cell population of monocytes (CD14 + cells) in the blood is continuously supplied in vivo from the bone marrow, and these cells migrate into the tissues (Hougee et al., 2005) , which is an effect that cannot be reproduced in the in vitro experimental conditions. It is reported that CD14 + cells were specifically eliminated in PBMC by apigenin and its structural analogues chrysin and luteolin. Thus, it is considered that the structure of CD14 + cell surface and that of drugs are important for the onset of toxicity. Therefore, the in vivo evaluation of the mechanism through which AGs exert their selective cytotoxicity to CD14 + cells is required.
In conclusion, we demonstrated that AGs increase the inflammatory responses and cytotoxicity of CD14+ cells via the p38 MAP kinase pathway in human PBMCs. These factors could be useful biomarkers for evaluating the toxicity of AGs. This study provides new insights into the evaluation of the toxicity of AGs in drug development.
This article has not been copyedited and formatted. The final version may differ from this version. PI or 7AAD assay, as described in Material and Methods. The data represent the means ± SD (n = 3). * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Dic. Human PBMC were treated with Dic, Dic-AG, Pro, Pro-AG, Tol, Tol-AG, Ibu, Ibu-AG, Nap, Nap-AG (100 μ M), or vehicle (1% methanol, Ctl) for 24 h. The IL-8 and MCP-1 mRNA levels were measured by real-time RT PCR and normalized with GAPDH (A).
The cell viability of CD14 + cells treated with Dic-AG was measured by 7AAD assay as described in Material and Methods (B). The data represent the means ± SD (n = 4). * P < 0.05 and *** P < 0.001 compared with the parent drugs. The data represent the means ± SD (n = 4). ** P < 0.01 and *** P < 0.001 compared with Ctl.
## P < 0.01 and ### P < 0.001 compared with Dic. subjected to immunoblot analyses using anti-Thr202/Tyr204 phosphorylated ERK1/2, anti-Thr180/Tyr182 phosphorylated p38 MAP kinase, and anti-Thr183/Tyr185 phosphorylated JNK1/2 antibodies. The data represent the means ± SD (n = 3). * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with Ctl. # P < 0.05, ## P < 0.01, and ### P < 0.001 compared with Dic. † P < 0.05 and † † P < 0.01 compared with Dic-AG. 
